This research suggests that early menopause may itself be a direct risk factor for cognitive decline, even when depression ...

Andrew Frank and Katherine C. Pearson, QUOI MediaAlzheimer’s disease is an insidious and relentless loss of memory and thinking, accompanied by a gradual ...

The global frontotemporal dementia market is experiencing robust growth due to the increasing prevalence of neurodegenerative disorders, advancements in diagnostic and therapeutic technologies, and ...

TOKYO – Japan is expected to lower the price of lecanemab, an Alzheimer's drug codeveloped by Japanese drugmaker Eisai Co.

In the fresh study, scientists at the China-Japan Friendship Hospital in Beijing ... according to the findings published in the Alzheimer’s and Dementia journal. Previous research on mice has ...

A collaborative team of researchers has succeeded in revealing the high-resolution structures of amyloid β (Aβ40) fibrils carrying the Tottori-type familial mutation (D7N) by leveraging the ...

Helicobacter pylori, best known for causing stomach ulcers, was shown to block the build-up of both amyloid-beta and tau in our study.

A Japanese research institute announced Tuesday that the final phase of a clinical trial testing a Parkinson’s drug as a potential treatment for familial Alzheimer’s disease has been underway ...

Lemborexant, a sleep aid, may protect against tau buildup linked to Alzheimer's, offering new hope for neurodegenerative disease treatment.

WASHINGTON – The first blood test to help diagnose Alzheimer’s disease will be available from late June in the US following regulatory clearance for its use last week, according to the ...

The FDA said it has issued its first official green light for a blood test to help diagnose Alzheimer’s disease, adding that it can help reduce the need for invasive samples or expensive | The ...